Cronos (CRON) Liabilities and Shareholders Equity (2016 - 2026)
Cronos (CRON) posted quarterly Liabilities and Shareholders Equity of $1.2 billion for Q1 2026, up 1.58% year-over-year from $1.2 billion in Q1 2025, and down 2.09% quarter-over-quarter from $1.2 billion in Q4 2025.
Cronos (CRON) Liabilities and Shareholders Equity (2016 - 2026) Analysis & Trends
Cronos' Liabilities and Shareholders Equity history runs 11 years deep, the most recent figure standing at $1.2 billion for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 1.58% year-over-year to $1.2 billion; the TTM figure through Mar 2026 stood at $4.7 billion (up 2.78% YoY), while the FY2025 annual figure was $1.2 billion, up 2.64% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $1.2 billion, down from $1.2 billion in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $1.4 billion in Q1 2022, with the low at $1.1 billion in Q2 2024.
- The 5-year median for Liabilities and Shareholders Equity is $1.2 billion (2026), against an average of $1.2 billion.
- The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity decreased 27.12% in 2022, then increased 7.72% in 2025.
- Cronos' Liabilities and Shareholders Equity stood at $1.2 billion in 2022, then decreased by 6.0% to $1.1 billion in 2023, then rose by 2.28% to $1.2 billion in 2024, then climbed by 2.64% to $1.2 billion in 2025, then declined by 2.09% to $1.2 billion in 2026.
- Business Quant data shows CRON's Liabilities and Shareholders Equity at $1.2 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.2 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 6.18 Bn |
| 10 | Cronos | 1.23 Bn | 437.76 Mn | 28.45 Mn | 1.18 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 Bn |
| Mar 31, 2026 | 1.17 Bn |
| Dec 31, 2025 | 1.20 Bn |
| Sep 30, 2025 | 1.18 Bn |
| Jun 30, 2025 | 1.18 Bn |
| Mar 31, 2025 | 1.15 Bn |
| Dec 31, 2024 | 1.17 Bn |
| Sep 30, 2024 | 1.18 Bn |
| Jun 30, 2024 | 1.09 Bn |
| Mar 31, 2024 | 1.11 Bn |
| Dec 31, 2023 | 1.14 Bn |
| Sep 30, 2023 | 1.15 Bn |
| Jun 30, 2023 | 1.17 Bn |
| Mar 31, 2023 | 1.16 Bn |
| Dec 31, 2022 | 1.21 Bn |
| Sep 30, 2022 | 1.24 Bn |
| Jun 30, 2022 | 1.33 Bn |
| Mar 31, 2022 | 1.37 Bn |
| Dec 31, 2021 | 1.40 Bn |
| Sep 30, 2021 | 1.54 Bn |